RARE
Ultragenyx Pharm (RARE)
NASDAQ
$25.98+$0.15 (+0.58%)
Price as of Aug 21, 2026 7:59 PM EDT
  • $2.5B
    Market Cap
  • -13.26%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 38
Valuation
RARE
vs History
vs S&P 500
Profitability
-0
Growth
-1
Low Earnings Volatility
3

Momentum Score

Score: 32
Valuation
RARE
vs History
vs S&P 500
3-Month Momentum
20.36%
12-Month Momentum
-8.47%
3-Month Risk Adjusted Momentum
84.50%
12-Month Risk Adjusted Momentum
-12.78%

True Yield

N/A
Valuation
RARE
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.08%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 44
Valuation
RARE
vs History
vs S&P 500
Ohlson's O-Score
6